Orthonika

Orthonika accelerates development of total meniscus replacement and secures additional funding

Orthonika Limited, a spin-out from Imperial College London, is pleased to announce success in securing funding for development of its novel synthetic total knee meniscus replacement. The company has closed a second round of...
SynbiCITE BrisSynBio4

Two new start-up plans win BrisSynBio’s first synthetic biology entrepreneurship competition

London, UK, 11th May 2017 / Sciad Newswire / Two start-ups' proposals have been chosen as the winners of the first competition to discover and accelerate new synthetic biology companies at the University of Bristol. The...
Alexandre Carpentier CarThera SonoCloud

CarThera to present data from phase 1/2a study focusing on disrupting blood-brain barrier for...

Paris, France, May 10, 2017 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that Dr. Ahmed Idbaih, AP-HP principal investigator of the Phase...
Medherant

Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer

Coventry, UK, 8th May 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, has appointed Laboratoires Plasto Santé to manufacture its first drug delivery...
biocon

Biocon Q4 FY17 Revenue Rs 974 Cr; Net Profit Rs 127 Cr; FY17 Revenue...

Biocon Q4 FY17 Revenue Rs 974 Cr; Net Profit Rs 127 Cr; FY17 Revenue at Rs 4,079 Cr; Net Profit at Rs 612 Cr Board of Directors Recommends 2:1 Bonus Shares  Bengaluru, Karnataka, India: April 27, 2017/ Biocon...
biowin

BioWin reports record investment in 2016, with €24.3 million ($25.8M) received by...

Gosselies, Belgium, April 26, 2017 – BioWin, a health cluster based in Wallonia, Belgium, today announces its review of 2016, based on a survey  conducted among its 164 members, revealing that: 2016 was a...
Vygon Group

Enteral feeding: Vygon Group launches safe-enteral.com

Vygon is keen to raise awareness amongst medical staff about the benefits of new standardized enteral connectors and the potential risks when used in premature neonates Ecouen, France, April 25, 2017 – Vygon, the single-use...
Domain Therapeutics

Domain Therapeutics and Pfizer Inc. enter into collaboration agreement on bioSensAll™

Strasbourg, France, and Montreal, Canada, April 25, 2017 - Domain Therapeutics, a France- and Quebec-based biopharmaceutical company specializing in the research and development of new drug candidates that target G protein-coupled receptors (GPCRs), today...
reviral

ReViral Announces Good Safety and Pharmacokinetics From Phase 1 Programme for RSV Antiviral RV521...

London, UK, 24th April 2017 / ReViral, a UK based biotechnology company focused on the discovery and development of antivirals for respiratory syncytial virus (RSV), announced today top-line safety and pharmacokinetic (PK) data from...
Synpromics

Synpromics Raises £5.2m Of New Investment

Edinburgh, UK, 19th April 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M. Participants included existing investors Calculus...